https://www.jpost.co...-patient-624653
Six critically ill coronavirus patients in Israel who are considered high-risk for mortality were treated with Pluristem’s placenta-based cell-therapy* product and survived, according to preliminary data provided by the Haifa-based company.
* Of course, those who voted against stem cell research will not be permitted the treatment.